marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Corvus Pharmaceuticals Financial Statements 2011-2024 | CRVS
Annual Financial Statements Corvus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
94.1 M | 30.7 M | 74.1 M | 103 M | 161 M | 107 M | 190 M | 214 M | - | - | - | - | - |
Shares |
48 M | 46.6 M | 41.9 M | 29.5 M | 29.3 M | 27.5 M | 20.5 M | 15.4 M | - | - | - | - | - |
Historical Prices |
1.96 | 0.66 | 1.77 | 3.48 | 3.44 | 4.84 | 8.19 | 14.4 | - | - | - | - | - |
Net Income |
-27 M | -41.3 M | -43.2 M | -6 M | -46.7 M | -46.9 M | -55.7 M | -36.4 M | -31.3 M | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-23.4 M | -32.6 M | -38.6 M | -43.8 M | -48.9 M | -49.2 M | -56.5 M | -37 M | -13.8 M | -161 K | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-23.3 M | -32.2 M | -38.2 M | -43.1 M | -48.1 M | -48.4 M | -55.7 M | -36.4 M | -13.6 M | - | - | - | - |
Operating Expenses |
23.4 M | 32.6 M | 38.6 M | 43.8 M | 48.9 M | 49.2 M | 56.5 M | 37 M | - | - | - | - | - |
General and Administrative Expenses |
6.88 M | 8.1 M | 9.52 M | 11.9 M | 10.9 M | 10.6 M | 10.2 M | 7.62 M | 2.42 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Corvus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
66.7 M | 59.7 M | 49 M | 49 M | 49 M | 47.5 M | 46.6 M | 46.6 M | 46.6 M | 46.6 M | 46.6 M | 46.6 M | 43.9 M | 42.2 M | 34.5 M | 28.4 M | 29.5 M | 29.4 M | 29.4 M | 28 M | 29.4 M | 29.3 M | 29.3 M | 29.3 M | 29.1 M | 29 M | 22.6 M | 21 M | 20.5 M | 20.4 M | 20.3 M | 20.9 M | 20.2 M | 20 M | 1.18 M | 1.43 M | 395 K | 346 K | 297 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-40.2 M | -4.26 M | -5.7 M | - | -6 M | -6.5 M | -7.87 M | - | -14.8 M | -8.36 M | -8.3 M | - | -10.7 M | -11.8 M | -11.6 M | 27.3 M | -9.8 M | -10.6 M | -12.9 M | -11 M | -11 M | -13 M | -11.6 M | -10.5 M | -10.5 M | -11.6 M | -14.3 M | -11.9 M | -12.7 M | -15 M | -16 M | -11.1 M | -10.3 M | -8.64 M | -6.35 M | -6.04 M | -3.15 M | -20.2 M | -1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-7.26 M | -5.94 M | -6.25 M | - | -5.56 M | -5.62 M | -6.57 M | - | -12.5 M | -7.01 M | -7.41 M | - | -9.05 M | -11.3 M | -11.5 M | - | -9.84 M | -10.8 M | -13.3 M | - | -11.5 M | -13.6 M | -12.3 M | - | -11.1 M | -12.3 M | -14.6 M | - | -12.9 M | -15.2 M | -16.2 M | - | -10.5 M | -8.82 M | -6.43 M | - | -3.12 M | -2.33 M | -2.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-7.24 M | -5.91 M | -6.23 M | - | -5.53 M | -5.59 M | -6.52 M | - | -12.4 M | -6.92 M | -7.33 M | - | -8.68 M | -11 M | -11.3 M | - | -9.36 M | -10.4 M | -13.1 M | - | -11 M | -13.2 M | -12.1 M | - | -10.5 M | -11.8 M | -14.4 M | - | -12.3 M | -14.8 M | -16 M | - | -10.1 M | -8.58 M | -6.32 M | - | -3.03 M | -2.3 M | -2.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
7.26 M | 5.94 M | 6.25 M | - | 5.56 M | 5.62 M | 6.57 M | - | 12.5 M | 7.01 M | 7.41 M | 6.81 M | 9.05 M | 11.3 M | 11.5 M | 9.88 M | 9.84 M | 10.8 M | 13.3 M | 11.4 M | 11.5 M | 13.6 M | 12.3 M | 11.2 M | 11.1 M | 12.3 M | 14.6 M | 12.2 M | 12.9 M | 15.2 M | 16.2 M | 11.2 M | 10.5 M | 8.82 M | 6.43 M | - | - | 2.33 M | 2.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.03 M | 1.82 M | 2.18 M | - | 1.6 M | 1.65 M | 1.98 M | - | 2.11 M | 2.09 M | 2.31 M | - | 2.06 M | 2.18 M | 3.25 M | - | 3.23 M | 2.91 M | 3.11 M | - | 2.52 M | 2.96 M | 2.89 M | - | 2.78 M | 2.54 M | 2.54 M | - | 2.21 M | 2.79 M | 2.72 M | - | 2.77 M | 1.71 M | 1.03 M | - | 606 K | 327 K | 290 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency